Which ETFs own GLAXO.NS?
GlaxoSmithKline Pharmaceuticals Limited · Healthcare · Drug Manufacturers - General · IN — 10 ETFs hold it, worth $41.3M across 1.42M shares.
Holdings as of Oct 11, 2026 · portfolio reporting dates from the data provider; not live positions.
| # | ETF | Weight | Shares | Value | ETF AUM | Category | Today | |
|---|---|---|---|---|---|---|---|---|
| 1 | SMIN iShares MSCI India Small-Cap ETF | 0.30% | 78.22K | $2.0M | $696.9M | Emerging Markets | +2.07% | |
| 2 | EMGF iShares Emerging Markets Equity Factor… | 0.11% | 80.14K | $2.1M | $1.93B | Clean Energy | -0.83% | |
| 3 | EEMS iShares MSCI Emerging Markets Small-Cap… | 0.06% | 8.67K | $227.0K | $390.0M | Emerging Markets | -0.44% | |
| 4 | VEXC Vanguard Emerging Markets Ex-China ETF | 0.02% | 1.44K | $46.0K | $269.4M | Emerging Markets | +0.03% | |
| 5 | GLOF iShares Global Equity Factor ETF | 0.02% | 1.29K | $33.8K | $202.1M | Developed Markets | -0.32% | |
| 6 | VWO Vanguard FTSE Emerging Markets ETF | 0.01% | 601.45K | $19.3M | $168.50B | Emerging Markets | -0.07% | |
| 7 | SCHE Schwab Emerging Markets Equity ETF | 0.01% | 50.67K | $1.3M | $12.90B | Emerging Markets | -0.14% | |
| 8 | IEMG iShares Core MSCI Emerging Markets ETF | 0.01% | 493.43K | $12.9M | $160.25B | Emerging Markets | -0.86% | |
| 9 | VSGX Vanguard ESG International Stock ETF | 0.00% | 7.55K | $241.6K | $6.80B | Developed Markets | -0.52% | |
| 10 | VEU Vanguard FTSE All-World ex-US ETF | 0.00% | 97.78K | $3.1M | $98.60B | Developed Markets | -0.36% |
Coverage reflects the ETF portfolios loaded in our database; very small funds may not be swept yet. Market data delayed approximately 15–20 minutes unless otherwise indicated.